touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • MDT perspectives on how GLP-1 RAs can reduce stroke risk

    touchMDT for touchNEUROLOGY

    Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D

    The multidisciplinary team

    • Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
  • Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
  • Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece

    • This touchPODCAST is for HCPs only.  

    This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchneurology.com/cme/mdt-role-glp1ras-in-modern-management-stroke-in-patients-with-t2d/ 

    15 min
  • MDT perspectives on how GLP-1 RAs can reduce stroke risk

    touchMDT for touchENDOCRINOLOGY

    Listen to key experts from a multidisciplinary team discuss how GLP-1 RAs can help to reduce the incidence of stroke in patients with T2D

    The multidisciplinary team

    • Primary care physician: Dr Yassir Javaid, Northamptonshire, UK
  • Consultant endocrinologist: Prof. Tina Vilsbøll, Copenhagen, Denmark
  • Consultant neurologist: Prof. Georgios Tsivgoulis, Athens, Greece

    • This touchPODCAST is for HCPs only.  

    This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchendocrinologyime.org/mdt-role-glp1ras-in-modern-management-stroke-in-patients-with-t2d 

    15 min
  • Immunogenicity of immune checkpoint inhibitors: Implications for clinical practice

    touchPANEL DISCUSSION for touchONCOLOGY


    Listen to a panel of leading experts discuss the clinical relevance of the immunogenicity of immune checkpoint inhibitors for the treatment of cancer, informed by experience in inflammatory diseases.


    The experts:

    Prof. Peter Galle, University of Mainz, Germany,

    Dr Victor Moreno, START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain,

    Dr Vibeke Strand, Stanford University School of Medicine, Palo Alto, CA, USA. 


    This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

     

    For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-immunogenicity/

    36 min
  • MDT perspectives on managing patients with complement inhibitors

    touchMDT for touchONCOLOGY

    Listen to key experts from a multidisciplinary team explore the use of complement inhibitors for patients with PNH.

    The multidisciplinary team 

    • Primary care physician: Dr Will Evans, UK
  • Haematologist: Professor Régis Peffault de Latour, France

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.


    For further information visit: touchONCOLOGY

    14 min
  • MDT and patient perspectives on recognizing and referring patients with PNH

    touchMDT for touchONCOLOGY

    Listen to key experts from a multidisciplinary team, and a patient with PNH, discuss the signs and symptoms of PNH and how these inform the clinical diagnosis.

    The multidisciplinary team

    • Primary care physician: Dr Will Evans, UK
  • Haematologist: Professor Régis Peffault de Latour, France
  • Patient: Ms Jess Ratcliffe, UK

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.


    For further information visit: touchONCOLOGY

    13 min
  • MDT and patient perspectives on the patient journey in PNH

    touchMDT for touchONCOLOGY

    Listen to a haematologist and a patient with PNH discuss the experience of living with PNH from a patient’s perspective.

    The multidisciplinary team 

    • Haematologist: Professor Régis Peffault de Latour, France
  • Patient: Ms. Jess Ratcliffe, UK

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.

    For further information visit: touchONCOLOGY

    14 min
  • Selecting the optimal treatment for patients with chronic myeloid leukaemia after two prior lines of therapy

    touchIN CONVERSATION for touchONCOLOGY

    Listen to two chronic myeloid leukaemia experts, Prof. Simona Soverini and Dr Daniela Žáčková  discuss the mechanisms of action and latest data for new and emerging treatment options for patients with chronic myeloid leukaemia after two prior lines of therapy, and how they might impact the management of chronic myeloid leukaemia. The discussion is guided by pre-canvassed questions from the chronic myeloid leukaemia clinical community.

    This touchPODCAST is intended for non-UK and non-US HCPs only. 

    This activity is funded by an unrestricted independent medical education grant from Novartis and is provided by touchIME.

    For further information visit our website: touchONCOLOGY

    30 min
  • MDT and patient perspectives on the diagnostic tools for non-CF bronchiectasis

    touchMDT for touchINFECTIOUS DISEASES

    Listen to key experts from a multidisciplinary team, and a patient, review the diagnostic tools for non-CF bronchiectasis.

    The multidisciplinary team 

    • Primary care physician: Professor Barbara Yawn, USA
  • Pulmonologist: Professor James Chalmers, Scotland
  • Radiologist: Professor Mary Salvatore, USA
  • Patient: Marta Almagro, Spain

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.


    For further information visit: touchINFECTIOUS DISEASES

    14 min
  • MDT and patient perspectives on the clinical presentation of non-CF bronchiectasis

    touchMDT for touchINFECTIOUS DISEASES

    Listen to key experts from a multidisciplinary team, and a patient, explore the key signs and symptoms of non-CF bronchiectasis and how these inform the clinical diagnosis.

    The multidisciplinary team 

    • Pulmonologist: Professor James Chalmers, Scotland
  • Primary care physician: Professor Barbara Yawn, USA
  • Patient: Marta Almagro, Spain

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.


    For further information visit: touchINFECTIOUS DISEASES

    15 min
  • MDT perspectives on the pathophysiology and comorbidities of non-CF bronchiectasis

    touchMDT for touchINFECTIOUS DISEASES

    Listen to key experts from a multidisciplinary team discuss the pathophysiology and comorbidities of non-CF bronchiectasis.

    The multidisciplinary team

    • Primary care physician: Professor Barbara Yawn, USA
  • Pulmonologist: Professor James Chalmers, Scotland

    • This touchPODCAST is for HCPs only.

    This activity is funded by an independent medical education grant from Insmed. This medical education is jointly provided by USF Health and touchIME.


    For further information visit: touchINFECTIOUS DISEASES

    12 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.